Granules India share price rises over 4% as Q3 net profit increases 28%
The scrip gained as much as 4.32 per cent to ₹589.40, the highest level since January 19 on the National Stock Exchange (NSE)
 "Granules India share price rose on Tuesday as third-quarter net profit increased")
Granules India share price rose on Tuesday as third-quarter net profit increased | Image: X/@GranulesIndia
Listen to This Article
Granules India share price today
Granules India's share price rose in Tuesday's session as the company reported an increase in net profit during the third quarter of the current financial year (Q3FY26). The scrip gained as much as 4.32 per cent to ₹589.40, the highest level since January 19 on the National Stock Exchange (NSE).
Granules India saw 1.4 million shares change hands on the NSE so far. As of 12:35 PM, Granules India stock pared some gains to trade 1.89 per cent higher at ₹575.55, as against a 0.21 per cent advance in the Nifty 50 index.
In the last 12 months, Granules India gained 5.99 per cent, as compared to a 10 per cent advance in the Nifty 50 index. The company has a market capitalisation of ₹14,006.84 crore.
CATCH STOCK MARKET UPDATES TODAY LIVE
Why did Granules India share price rise today?
Granules India saw some increase in buying interest as the company reported a 28 per cent year-on-year (Y-o-Y) increase in the December quarter. The net profit was at ₹150.2 crore versus ₹117.6 crore in the same quarter a year ago
Also Read
 "Indian shrimp sector crisis, US tariffs on shrimp exports, shrimp export losses India, $1 billion shrimp loss, vannamei shrimp exports, 50 count shrimp price drop, farm-gate shrimp prices India, Rs 70/kg shrimp price fall, Indian seafood export impac")
 "Hyundai Alcazar")
 "ITC q3 results preview")
 "Adani Enterprises share price in focus")
 "Stocks to buy ahead of Budget 2026: BEL among top analysts bets in agri, defence sectors.")
Granules India reported that its total income increased 22 per cent Y-o-Y to ₹1,387.9 crore in Q3FY26, from ₹1,138 crore, according to an exchange filing.
During the third quarter, the earnings before interest, taxes, depreciation, and amortisation (Ebitda) rose 34 per cent to ₹230.3 crore from ₹308.1 crore in the same quarter a year ago.
The finished dosage segment in North America and Europe drove the growth in the pharmaceutical company’s revenue, Granules India said in the Investors’ Presentation. The better product mix in the segment also helped the gross margin expansion of 216 basis points Y-o-Y. The share of finished dosages continues to grow across the quarters, Granules India said.
ALSO READ | Apex Frozen Foods zooms 19% on heavy volumes; what's driving seafood stock?
Technical view: Granules holding above long-term, short-term averages
Granules is holding strong above its long-term as well as short-term moving averages despite the weak broader market. The formation of higher-highs and higher-lows is another sign of strength in the ongoing upmove, said Vipin Kumar, assistant vice president, technical and derivatives research, Globe Capital Market.
Current chart structure points toward a buy on dips trading approach, provided it continues to trade above ₹530 levels on a closing basis. Conversely, the ₹620-₹630 zone will act as immediate resistance on the higher side, he added.
==============
Disclaimer: View and outlook shared belong to the respective brokerages/analysts and are not endorsed by Business Standard. Readers discretion is advised
More From This Section
 "Sensex, Nifty, stock markets, record highs, profit booking, RBI, Federal Reserve, earnings, valuations, IT stocks, market breadth")
 "Nilesh Shah, MD, Kotak AMC")
 "Asian stocks, Asian shares")
 "MCX")
 "DCB Bank share price surged to six-year high on January 27,2026")
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Jan 27 2026 | 1:03 PM IST